Gandy S E, Buse M G, Crouch R K
J Clin Invest. 1982 Sep;70(3):650-8. doi: 10.1172/jci110659.
Copper-zinc superoxide dismutase (SOD) is present in relatively high concentrations in the beta-cells of human islets. The activity of the extracted enzyme is partially inhibited upon incubation with the diabetogenic drugs alloxan, streptozotocin, or Vacor. The role of this enzyme in protecting beta-cells against chemically induced diabetes was further investigated. Incubation of intact canine islets with alloxan (0.2 mg/ml) and 4 mM glucose decreased the insulin secretory response by 87% during subsequent exposure to 28 mM glucose. Concomitantly the SOD-specific activity (units of enzyme activity per milligram immunoreactive SOD) decreased 50% in alloxan-exposed islets. When islets were protected from alloxan toxicity by including 28 mM glucose with alloxan, the insulin secretory response and SOD specific activity remained identical to controls. Thus, SOD specific activity correlates with maintenance of beta-cell function. To test the effectiveness of SOD against streptozotocin in vitro, canine islets were incubated 10 min with or without streptozotocin (0.1 mg/ml) with 4 mM glucose; their functional integrity was tested subsequently as the insulin secretory response to 28 mM glucose. Exposure to streptozotocin alone decreased the response by 70%; inclusion of SOD (1.5 mg/ml) before and during exposure to streptozotocin completely prevented this effect. Cyanide-inactivated SOD was not effective. The potential of SOD to prevent streptozotocin-induced diabetes was tested in rats in vivo. SOD injected 10 s or 50 min before streptozotocin prevented or significantly attenuated diabetes. Injection of SOD and streptozotocin simultaneously was much less effective, and cyanide-inactivated SOD was ineffective. No protection was afforded by injection of SOD 12 or 24 h before streptozotocin. Our results support hypotheses that (a) oxygen radicals mediate the beta-cell toxicity of both alloxan and streptozotocin, and (b) beta-cells may be particularly vulnerable to oxygen radical damage.
铜锌超氧化物歧化酶(SOD)在人胰岛的β细胞中含量相对较高。将提取的酶与致糖尿病药物四氧嘧啶、链脲佐菌素或灭鼠优一起孵育后,其活性会受到部分抑制。进一步研究了这种酶在保护β细胞免受化学诱导糖尿病方面的作用。将完整的犬胰岛与四氧嘧啶(0.2 mg/ml)和4 mM葡萄糖一起孵育,随后在暴露于28 mM葡萄糖期间,胰岛素分泌反应降低了87%。同时,在暴露于四氧嘧啶的胰岛中,SOD比活性(每毫克免疫反应性SOD的酶活性单位)降低了50%。当胰岛通过将28 mM葡萄糖与四氧嘧啶一起孵育而免受四氧嘧啶毒性影响时,胰岛素分泌反应和SOD比活性与对照组保持相同。因此,SOD比活性与β细胞功能的维持相关。为了在体外测试SOD对链脲佐菌素的有效性,将犬胰岛在有或没有链脲佐菌素(0.1 mg/ml)和4 mM葡萄糖的情况下孵育10分钟;随后通过对28 mM葡萄糖的胰岛素分泌反应来测试其功能完整性。单独暴露于链脲佐菌素会使反应降低70%;在暴露于链脲佐菌素之前和期间加入SOD(1.5 mg/ml)可完全防止这种效应。氰化物灭活的SOD无效。在体内大鼠中测试了SOD预防链脲佐菌素诱导糖尿病的潜力。在链脲佐菌素之前10秒或50分钟注射SOD可预防或显著减轻糖尿病。同时注射SOD和链脲佐菌素的效果要差得多,而氰化物灭活的SOD无效。在链脲佐菌素之前12或24小时注射SOD没有提供保护作用。我们的结果支持以下假设:(a)氧自由基介导四氧嘧啶和链脲佐菌素对β细胞的毒性,以及(b)β细胞可能特别容易受到氧自由基损伤。